Transcript 0:00 Hey, folks. It's Quinn. Since we recorded this conversation, we've renamed the podcast. It used to be called Important Not Important, which is what you'll hear in the episode and is still the name of the company. 0:12 But now the podcast is called The Most Important Question. That is, what can I do? 0:18 It's the question we get the most from all of you, and it turns out it's the question I've really been asking guests for almost two hundred episodes now. So here we are, The Most Important Question. 0:29 Please enjoy this old conversation. Thanks for listening, and thanks for giving a shit. [upbeat music] Welcome to Important Not Important. 0:45 My name is Quinn Emmett, and this is science for people who give a shit, like you. Folks, there's a lot going on out there. Our world is changing every single day. 0:55 We give you the tools you need to feel better and to fight for a better future for everyone. That includes the context straight from the smartest people on Earth and the action steps you can take to get involved. 1:07 Our guests are scientists, doctors, nurses, journalists, uh, farmers and educators, CEOs and founders, astronauts, even a couple reverends. Some quick housekeeping before we get to the episode. 1:21 A reminder, you can send questions, thoughts, and feedback to us on Twitter at importantnotimp or on email at questionsatimportantnotimportant.com. That's also right there in your show notes. 1:33 You can also join tens of thousands of other smart folks and subscribe to our free weekly newsletter at importantnotimportant.com. 1:40 And that's the most important science news plus analysis and action steps once a week on Fridays. You can hunt for a new impactful job on the front lines of the future at importantjobs.com. 1:53 If you work for a company or organization already doing that kind of work, from climate change to maternal health, uh, to mosquitoes, you can list your open roles there for very affordable rates and get them in front of our entire incredible community, again, of scientists and designers and, and writers and product managers and engineers of hardware and software, uh, all of them. 2:15 We are so lucky to have them and excited to help them take that next step. 2:19 Folks, this week's episode is going to help you understand the growing mosquito problem, uh, which is really saying something when those little bastards have killed more people than basically anything ever. 2:32 Our guest is the wonderful Dr. Omar Akbari, and he is one of the world's preeminent biotechnology and mosquito researchers. 2:40 I learned so much about what's changing in the mosquito world, which now very much includes California, and that includes, uh, factors like climate change and also gene drives, which we talked about in one previous episode, and that has changed a little bit since, uh, since then. 2:57 Um, we also talked about how a virus like, uh, SARS-CoV-2 or, uh, the disease COVID-19 could level up into something mosquitoes find hospitable, and then that's basically all she wrote. So please enjoy this episode. 3:11 I hope you find something useful out of it. And, uh, again, send us feedback and, uh, we'd love to hear it. Thanks. [upbeat music] My guest today is Dr. 3:23 Omar Akbari, and together we are going to, gosh, what's m- the best metaphor here? Take a bite out of the, uh, the big mosquito question. How much of a problem are they globally? 3:34 Uh, shed some more light on that for everyone in the global north or, or Western world, and how is that changing for everyone, and how did we get lucky when it came to, to COVID, and what does that mean for the future? 3:45 Uh, Dr. Akbari, welcome. Thank you so much. I'm so happy to be here today. For sure. Omar, if you could, could you tell us real quick, uh, who you are and what you do? Yeah. 3:55 Uh, my name is Omar Akbari, and I'm a associate professor at University of California San Diego. 4:00 I, I run a lab, and we, we do a lot of research on insect vectors, um, also on crop pests, um, and I also teach, um, molecular biology at, at UCSD. Wow. All right. 4:12 So g- you got a, you got a few arrows in the quiver there, for sure. Oh, yes. It-- Yes, I do. That's awesome. 4:19 Uh, well, I'm-- we're, we're glad you haven't settled for one, one boring topic and, and you're taking on all these. So thank you, sir. Dr. Akbari, we like to start with one kind of ridiculous question. 4:30 It's a little tongue-in-cheek, but it-- we feel like it does set the tone for, for things. 4:34 Instead of saying tell us your entire life story, uh, I'd like to ask, uh, doctor, why are you vital to the survival of the species? And I encourage you to be bold. [laughs] Have fun with it. 4:46 Well, you know, I, I would say that we are doing research which will benefit humanity. You know, we work on mosquitoes, and mosquitoes are, are considered to be the world's deadliest animal. 4:58 Um, they kill more people on Earth than any other animal combined. 5:02 Um, there was actually an article that came out today, uh, in The Guardian that, that says, you know, the climate crisis is gonna put eight billion, uh, people at risk of malaria and dengue fever, um, and that is gonna be in fifty years from now. 5:15 So this-- the problem is not going away. It's getting worse progressively, and the tools that are presently available to combat this problem are, are not working, right? 5:27 So I would say I am here to benefit humanity by, by hopefully developing new tools to combat, uh, mosquitoes and other pests. Wow. 5:38 Um, I did see that article in, yeah, our newsletter's about to go out, uh, today and f- this is, uh, recording July ninth. Um, and yeah, you see that number, and you kind of blink and go, "Eight, eight billion?" 5:50 So basically everyone at that point? That's, uh, that's something else. Yeah. That's something else. Yeah. 5:56 Well, so before we get into to all of that, you know, I, I wanted to have this conversation today and kind of thinking about where we'll go with thisI mean, I'm sure you're aware through your work and, and to most folks out there, uh, unless you have lived in Washington, DC, and stuff like that, uh, to, to most of the global north a- as it's put, you know, barring a, a Zika outbreak, uh, mosquitoes can be... 6:23 seem like very small potatoes. They're obnoxious, but they're not a, a threat necessarily to, to most folks in, in the Western world a lot of the times. 6:33 Um, but in, in the rest of the world, that's very much not the case, and it is getting more real here, uh, every day, uh, like you said with the, with the dengue article there, which we'll, we'll definitely put in the show notes and, and talk about a little bit. 6:47 So w- we need to be educated on not only what's coming our way and changing in places like, uh, Los Angeles and Southern California, where one of the biggest bragging rights has usually been, like, no bugs, a- and that that's changing quickly, but we also need to do a better job understanding how the rest of the world has been dealing with, uh, mosquitoes and the diseases they carry for, for a very long time. 7:10 You know, what, what, what has been learned there and what can be applied here, if, if anything, and, and what do the next five, 10 years look as we consider some of these newer technologies and, and efforts to, um, to reduce the sicknesses and the deaths in a lot of cases that are driven by mosquito travel. 7:28 Does that make sense? Is that... am I barking up the right tree? Yeah. I, I think you're, you're definitely barking up the right tree. Th- you know, in the... 7:34 like you said, in the global north, there's not, there, there's not as much problem in terms of disease transmission by mosquitoes. 7:40 We don't, we don't, you know, we don't really have malaria transmission in the United States, for example, and- Mm-hmm... 7:45 and dengue, dengue transmission happens occasionally, um, but it's not, it's, it's not s- as significant as it is in, in other parts of the world. 7:53 You know, that said, there, there is some diseases that are transmitted, um, in the United States, you know, like West Nile virus- Mm-hmm... and St. 7:58 Louis encephalitis, and, um, there was actually an article that came out I think yester- yeah, yesterday that basically said there's seven states now that have, um, West Nile transmission happening in, in the- Wow... 8:10 within the United States. 8:10 So, you know, there are, there are definitely mosquitoes that are transmitting diseases in the United States currently, and, and the ones that transmit the, the very harmful diseases like dengue, Zika, chikungunya, yellow fever, they're here. 8:23 You know? Mm-hmm. They've, they've recently invaded the United States. They're, they're here. They're, they're s- they've spread throughout California. They're in my backyard, right? 8:30 My kids get bit by, by them and, and these are Aedes aegypti and Aedes albopictus. And so- Right. Right... you know, while we don't have local transmission of dengue happening in California, right? That, that doesn't... 8:41 Yet, yeah. So I mean, you know, as people start traveling, right? Again, post-COVID, you know, they... it's possible they'll, they'll go to places where there is dengue. They could... and they could bring it back, right? 8:52 And the mosquitoes are here. They'll bite them and, and then transmit locally. So it's just a matter of time really. Yeah. Well, I'm excited to help folks understand that context. 9:02 I mean, that's one of the biggest things as much as we, we try to drive, uh, action here, r- like I, I mentioned to you offline, it's, it's so important to have context for, for why we're doing it and why it's necessary, uh, in this moment and what's changed to provide it and what we can change by taking action. 9:19 You know, it's, uh, again, not to minimize something like COVID, which has obviously been h- horrendous and horrific in so many ways and to so many marginalized groups as it is, but, you know, it's the same reason we push, uh, you know, big, uh, legislative and also NGO action and, and things like that on something like air pollution, which kills millions of people every year and is pretty easily fixable. 9:45 It's a, it's a policy, policy choice. 9:47 Something like mosquitoes is obviously a little more complicated in a lot of ways, but like you said, it's, it's happening and it's changing quickly, so we should, we should talk about it. 9:56 So one of the things that really stuck out to me, uh, in, in looking into this stuff again for, for sort of the second time and, and reading some stuff, uh, that y- that you've been part of, it... 10:07 for a while, we d- just for backstory, we, we didn't really h- h- everyone remembers, we didn't really have a great handle on how, uh, you know, SARS-CoV-2 spread, the, the virus that leads to COVID. 10:16 We, we all washed our hands and all of our groceries like crazy, and, uh, s- everybody was told not to do masks 'cause theoretically the large droplets shouldn't have gotten through, and 'cause we didn't have enough masks, and the frontline health workers needed them, and th- then we all slowly came around to the fact that it's probably comes down to aerosols or, or airborne transmission. 10:37 And so masks became, and, and we verified that's an incredible tool, but early on, you were quietly testing to make sure, uh, sort of almost worst case scenario, that COVID wasn't being spread by mosquitoes like some of these other diseases you mentioned, like malaria a- and dengue and West Nile. 10:55 I, I wonder before you talk a- about that, did you do that testing 'cause that's a sort of a standard practice when there's a novel virus or pathogen, or because there was a fear or even a possibility or probability that it was the case? 11:10 T- tell me how that works in your lab when, when you see something like that show up. Um, great question. So, so just to, just to clarify, you know, our, our lab didn't actually do tho- those tests, um- Sure... 11:21 to determine whether, um, Zika was transmiss- transmissible by mosquitoes. It, it was done by another group, but, you know, these mosquitoes that, that, you know, they're capable of transmitting viruses. 11:31 They transmit many viruses, and, and so when you have a novel virus that, that, you know, um, comes on the radar, it's, it's always good to see if, if these vectors could p- possibly transmit it, and, and that's what was done here. 11:44 Um, in particular, they tested whether Aedes aegypti and a few other vectors could transmit Zika, uh, um, or not Zika, I'm sorry, uh, SARS-CoV-2 and, and they found that, you know, they, they could not. 11:56 So I think, you know, it, it, it was a really great thing that they, you know... it w- it... the pandemic has been horrible, and it still is horrible. 12:04 You know, we're still all, you know, dealing with it and, and suffering from it, so wearing a mask seems to work, right? Because ma- majority of transmission happens through airborne droplets.Right? Yeah. 12:14 So, I mean, mask-wearing really, really helps, and you know, you can, you can prevent spread that way. But you can't really... It's, it's really difficult to prevent a mosquito from biting you. So if it- Mm-hmm... 12:26 if it was transmitted by mosquitoes, then, you know, just imagine what the quarantine would look like, right? [laughs] People might be hiding in their bathrooms, you know, to prevent, uh- Sure... 12:36 you know, with, with masks to prevent both airborne droplet and mosquito- mosquitoes from biting them. You, you wouldn't want to go outside, you know? Mm-hmm. 12:43 Um, and these mosquitoes, you know, a lot of them can bite during the day, um, and they, and they live around our household in small containers. 12:51 They breed in small containers, so they're- they've, they've sort of adapted to, to living in, in human habitats, and so they're really difficult to control. 13:01 And so I think, you know, had it, had it been the case, it, it would just would have been a much more severe situation. 13:06 So could you, could you put any, obviously entirely hypothetical, but again, just so people understand in talking with... 13:13 And again, the, the, the diseases that the mosquitoes carry are obviously all different and in a variety of ways and the, the SARS-CoV-2 virus is obviously different from, from those. 13:24 But I guess putting it up against, and a- again, u- apologies if this doesn't make any sense whatsoever, but putting it up against what we know so far about the airborne aerosol transmission, how would the situation have been different, uh, not just practically hiding in our bathrooms, which I, I mean, at that point you got nowhere to go. 13:41 You can't even open a window to get air trans or to get air flow, like w- we've learned is important. 13:46 H- how would practically that have been different, I guess, possibly transmission-wise if something like SARS-CoV-2 was carried by mosquitoes? What... I guess, what are we looking like, you know, as, as that grows? Yeah. 14:01 I mean, it's really hard to put a number on that, but, but what I can- For sure... what I- I guess more scope. Yeah. I mean, what, what I can say is that, you know, it, you know, there's an... 14:10 It just would depend on what species of mosquito i- is transmitting, and 'cause different- Okay... species prefer different climates. 14:17 But, but I will say that, you know, it's estimated that one half of the world is presently at risk of being, uh, of being infected by dengue virus, right? 14:25 Because the mosquito is present in, in pretty much over half of the world, uh, you know, half of the world. They live in areas, uh, that, that, that, uh, cover half of the world. 14:35 So if the mosquitoes are, are present, right? And, and we all know that, that pr- SARS-CoV-2 has basically spread everywhere, right? 14:43 Then you just, you just would have this increased likelihood of transmission that would, that would have been a result of, of mosquito bites. 14:51 Um, but again, thankfully, thankfully it wasn't the case, but, you know, what's gonna happen, what, what, what is the next pandemic gonna be, right? The previous epidemic was Zika virus, right? 15:01 And that, and that, you know, was spread by mosquitoes, and, and it, and we saw s- you know, uh, s- you know, it, it was a scary time when, when you see these babies on, on the news that have microcephaly because of a, a mosquito-borne virus, so thankfully that wasn't also airborne via droplets, you know? 15:20 But if it was, then that, that could have been far worse. 15:23 So I think we, we need to figure out a way to deal with these mosquitoes, you know, that, that, that is effective, that doesn't, you know, rely on just spraying chemicals into the air that, you know, are gonna kill the mosquitoes but also are gonna kill other insects and, and- Sure... 15:40 possibly harm us as well- Sure... or our kids. We need better solution. And, and the insecticides is, you know, there, there, there's been documented resistance. 15:49 You know, mosquitoes have evolved resistance to these insecticides. They're not as- Mm-hmm... effective as they used to be. 15:53 So we just need new solutions for when the next pandemic does happen, if it happens to be transmissible by mosquitoes, what are we gonna do? Sure. And if you could, um, 16:06 a- again, if you could educate me and, and the rest of us, uh, w- w- again, to try to understand some context, something like dengue or malaria or Zika, how often do those have sort of 16:20 a, a variety of pathways of transmission, so not just airborne, but also surface, not just airborne, but also, uh, by mosquito? Is, is that something that's common or would that be a pretty rare situation? 16:34 I, I think it would be a pretty rare situation. So, so all the pathogens that I've mentioned are, are vectored by mosquitoes, and, and mosquitoes are required for transmission. 16:43 Um, so you know, it, it would be rare, but, but it's, it, it's not out of the realm of possibility. So I think, you know, we just need to be prepared. How... 16:53 If you could, uh, go one step deeper with me, because I have a bunch of small children and all they do is ask why, why, why, and I'm trying to apply [laughs] that in, in some of these bigger questions. 17:02 How does a, how does a, a virus evolve to require a mosquito? Like, we know that viruses need a host, um, and with every host, it's a chance to either i- infect, make sick, or kill someone. 17:14 But if it kills someone, it has, it doesn't have anywhere, uh, to go unless it's gone somewhere else, but what, what is specific about to those viruses and mosquitoes? Why, why mosquitoes? 17:25 Well, you know, the viruses, you know, they, they, they have hosts and they have vectors, right? Mm-hmm. And, and the host is, is oftentimes, you know, an animal or like us, for example, humans. 17:38 And so, you know, the virus is present in our blood, and mosquitoes need blood to, to, to, to propagate. So it's... 17:45 For mosquitoes to have progeny, mos- female mosquitoes have to take a blood meal, and so it's an opportunity for the virus to enter the mosquito, right? And not all viruses are transmissible by mosquitoes. 17:57 A lot of them, the mosquito immune system is able to sort of prevent the replication of those viruses, but some viruses are able to escape that, right? Mm-hmm. 18:06 Um, and, and these viruses, like dengue virus and Zika virus, for example, are, are really not predicted to, to harm the mosquito in, in any negative way, right? So they, they make it- Hmm... 18:17 into the mosquito through a blood meal that the mosquito gets from its host, and then-They sort of evade the immune system of the mosquito, and then they're able to be, um, replicated and then transmitted to the next, um, victim So you know, I, I, you know, certain viruses ha-have been able to evolve that, that... 18:38 those features over time and, and well, while many of them, you know, um, get, get selected, selected against, you know. So yeah, it's just... 18:48 I, I don't really-- We don't really understand exactly how that works, but, um- Mm-hmm... but we know it happens and, and, um, and so there are many viruses that, that are transmissible, transmissible by mosquitoes. 18:58 I guess that's one thing that's really interesting is where a virus like, uh, like a coronavirus is, is going to affect its host as well as, you know, seek out other hosts through a variety of vectors and, and transmission options, 19:14 but you said, uh, th-those viruses don't actually affect the mosquitoes. Is that correct? Yeah. So, so, you know, they're, they're... When you, when you do fitness experiments on infected- Mm-hmm... 19:26 mosquitoes versus- Mm-hmm... non-infected mosquitoes, there's not... in a lab, there's not, there's not a significant difference. There's no real- Huh... 19:34 obvious negative consequence of being infected by the virus o-on the mosquito, right? So that, that enables the, the, the virus to sort of, to persist and to be spread. Sure. Right? 19:45 Because if it, if it were to negatively affect the host or, or the vector, I mean, um, let's, let's say, you know, when the virus gets in the mosquito, it kills the mosquito, well, that would be... 19:55 that wouldn't be an, um, ideal scenario for the virus, right? Because then the virus would quickly get selected, selected against because it would just kill all, all of the vectors. 20:04 So, so there, there has to be this, this, um, balance, right, where- Mm-hmm... um, you know, it's, it... In, in order for the virus to spread, it doesn't wanna negatively affect the vector. 20:18 So that, that reminds me of the difference between, a-am... among many differences, but the difference between, uh, as we described it, uh, SARS or SARS Co- 20:30 you know, the disease that came from SARS-CoV-1 and how much more, uh, how much higher the, the fatality rate was from that than, uh, than SARS-CoV-2 and as we've described it, COVID-19, which where so many of the cases were asymptomatic. 20:46 And, and while those people had lower viral loads from as far as we can tell, it enables, it still enables the, the virus to spread further, to transmit further because it's not killing the hosts as often. 20:58 Am I misunderstanding that? No, you're, you're exactly right. You know, the, you know, the... You know, if the virus is going to, to kill its, its host, um, you know, then, then it's not... 21:10 it's, it's less likely to be spread, um, as- Mm-hmm... as far. So SARS-CoV-2, you know, like you said, there was a many asymptomatic cases and, you know, that contributed to the, the widescale spread, right? Mm-hmm. 21:24 That's, that's still ongoing. And, you know, it's, it's... in some ways, it's, it's the perfect, um, storm, right? Sure. 21:31 You have a, a virus which, which can be lethal, but in most cases it's not, um, and it can, it can go undetected and, and enable its, its rapid spread through air droplets. I mean, it's, it's- Right... 21:45 it's the perfect storm for, for, um, a pandemic. And it's, it's interesting, and this is probably a different conversation. I mean, I've, I've [chuckles] had it quite a few times, but we don't need to go down this route. 21:56 But, you know, what, what made this, uh, 22:00 more deadly to, to certain groups, um, and turned out to be many of the most marginalized groups in America were the preexisting cardio-respiratory and cardiopulmonary conditions that already existed, which, uh, were one layer of what made, what makes, uh, COVID-19 more deadly to many of those groups because of the way it operates once it's in your body, uh, versus healthy white young people, for example, who certainly have been affected, but not nearly as, as, uh, as fatally as, as many of those groups. 22:33 But then also, again, like you said, because it is able to transmit so much more, I guess, silently [chuckles] or subtly, you see it transmitting so much more effectively in these places where, again, many of those same groups are living in multi-generational households or working in meat factories or whatever it, it may be. 22:54 It's... People weren't dropping dead immediately, so it was able to keep passing through them, uh, pretty quickly. Right. That's exactly, exactly the case. It's, it's super unfortunate. 23:03 So I wanna understand a little bit about this specific mosquito that, that you mentioned, and I'm gonna definitely mispronounce its name, Aedes, uh, aegypti. Can you, can you do a better job of that for me? Yeah. 23:17 Aedes aegypti. Aedes aegypti. Oh, damn it, so close. So, Doc, w-what is it and why is it so much more dangerous versus other mosquitoes? 23:27 Or maybe I'm misunderstanding that, but can you talk a little bit about what it is and what it does and, uh, how it lives and why it's so different? Right. 23:35 Um, I mean, Aedes aegypti is an invasive mosquito originating from Africa, and it spread throughout, you know, the Americas during the slave trade, and it's, you know, it's present throughout the United States and, uh, Central and, and South America. 23:50 It transmits a number of different viruses. So it transmits dengue, Zika, yellow fever, chikungunya virus, for example. Mm-hmm. Um, and it also, it also is a, a species that has 24:02 evolved to sort of prefer to live, um, in, in human, like in where humans live. Um, and it, it, um, prefers to breed in these small little containers. 24:14 So, so even, you know, uh, a bottle cap from a soda bottle, for example, if it had, um, if it was full of water from rain-You know, a aegypti would actually lay its eggs in that, and, and, and that's, you know... 24:26 So it can- Mm-hmm... it can propagate in very small, uh, pools of water. And it also prefers to bite during, during the day. 24:34 And it can-- And, and it lives-- It, it can hide in our households, and it's, it's, it's an extremely intelligent species. And also its bites, you know, when it bites you, you don't really feel anything. 24:46 It, it doesn't hurt at all. So- Hmm... it's an, it's, it's just really efficient at, you know, at, at sort of dwelling with humans and, and transmitting pathogens. 24:54 So it's, it's one of the ones we need to, to really worry about, um, here in the United States because it's now, it's now become relatively abundant. That's super helpful and, and more or less terrifying. 25:06 I mean, it sound like [chuckles] every, every one of those beats was, uh, something specifically engineered to be super effective, including the fact that you don't really notice when it bites you. Which, uh, unlike, 25:17 for example, a snake bite, uh, where you, where in some cases you have a limited amount of time to get the venom out, for example, um, or take an antidote, uh, there's, there's... 25:26 I, I imagine there's not really anything like that, uh, when you, when you can't tell and when it's biting all day versus dusk, which is I think how a lot of folks imagine mosquitoes to, uh, be prime hunting hours. 25:39 E-exactly right. You know, and, and they're, and they're also, um, incredibly intelligent as well. 25:43 You know, there's been studies where they've, they've actually done, um, sort of conditioning, and they, and they found that, that these mosquitoes are able to learn, um, you know, and, [chuckles] and adapt rela-relatively quickly. 25:57 So, like, when you... For example, when you, when a, when the mosquito lands on you to bite, if you swat it away with your hand, it, it'll learn from that, and it, it, it won't... 26:06 You know, it'll learn that, that, that's something that they should avoid, and, and, um, and next time it'll, it'll sort of adapt and, and bite a different spot. 26:14 And so it, it's, it's really, um, fascinating actually that, that they're... how intelligent they actually are. I'm glad that you find it fascinating. For me, [chuckles] it's just like, oh my God, that's wild. 26:26 I mean, we, we, humans do a poor enough job, um, extending the, the term intelligence to a, you know, a huge variety of, of species on this planet that, that deserve it. 26:37 But that is pretty, pretty wild for something, an organism that we m- uh, I guess laymen, especially myself, don't consider that complex. Um, that's pretty incredible. 26:47 So I, I, I know, and again, I mentioned I've spent most of the past twelve years in Los Angeles. 26:52 I'm kind of back to the East Coast now, but, you know, one of the bragging rights of Southern California, besides it used to be mildly sunny and warm, which is not so much the case anymore either, and I guess kind of goes part and parcel with this, we didn't used to have a lot of bugs, and now we do. 27:08 Can you talk about this mosquito showing up in California and Southern California and, uh, what that has done, how much it's spread, and, and I guess how, you know, this climate crisis and, and how it's getting so much hotter in a lot of these places, why are they becoming breeding grounds for, uh, this serial killer of a mosquito? 27:30 Right. Yeah. I mean, this mosquito prefers warmer climates, so as, you know, temperatures warm through global warming, you know, it's, it's actually expanding its, its, its habitable range. 27:42 And, you know, back to California, it, it invaded California in two thousand twelve. 27:47 So it was first found, um, you know, in, in parts of Southern California in two thousand twelve, and, and since then, it's, it's basically spread throughout the entire state. Um, it's found in pretty much all counties. 28:00 And, and, you know, I mean, I live in San Diego, and in my backyard, I, I find them, you know, at, uh, you know, right around, uh, during the day when I'm working in the yard or even at dusk, I, I find them and I catch them, and I have a little microscope in my office and I bring them in just to confirm that they are, they're what I think they are, and they are what I think they are. 28:20 And so it's a pretty big problem. I think we need to, we really need new tools to, to, um, to address, to address this. For our West Coast listeners, how, how much have they spread since two thousand twelve? 28:32 Is this a fairly, uh, s-sporadic, I guess, weak yield, or, or have they, have they really, uh, infiltrated the place? 28:41 I mean- Um, because I think a lot of people that have been there for a long time don't really realize the extent of it, unless I'm misunderstanding it, which is- Yeah... more or less how my day goes. No. 28:52 I mean, you know, they've, they've, they've spread throughout the entire state, and unfortunately in California, there's, there's really good, uh, vector control programs throughout the state. 29:01 And in San Diego, we have a really good program too. And prior to their, you know... 29:07 Y- this, this vector control program, like, like many, actually will trap mosquitoes and bring them back to the, their labs and, and sort of speciate them so they know sort of what species are present, you know, in the population. 29:19 And, and what's happening now is, is this species ac- is actually becoming the dominant species that's, that's found in these traps, right? So that's telling you that it's actually... It, it's not just sporadically here. 29:31 It's, it's kind of invaded and it's, um, it's here, it's here to stay, and it's becoming the dominant vector. Good times. Okay. 29:41 Uh, well, that's, that's helpful to know to, again, s-set the, set the table for folks to, again, further understand that this is not just, um, a, an issue that's in Africa or otherwise, that it's not just a Zika issue in Florida. 29:53 It's, it is everywhere, and especially in California, which is, uh, as we can tell, uh, getting quite a bit hotter. 30:00 Um, to, just to pivot a little bit, uh, Omar, i-in, I think late twenty nineteen, mid-twenty nineteen, and I alluded to this offline, we had our first conversation about mosquitoes, uh, with a woman named Detter, Dr. 30:13 Natalie Kofler. Uh, and she's a molecular biologist, I believe. She's teaching at Harvard Medical School, and she founded, um, Editing Nature. 30:22 Uh, and they're basically aAgain, as I understand it, a working group trying to explore and push folks around the world to conduct serious ethical investigations. 30:32 So not just with the microscope, not just m- not to minimize that, but really, you know, taking the sort of liberal arts view of before we just genetically modify a, a bunch of male mosquitoes or what have you and let them loose in the wild, asking those questions of, of, of should we? 30:51 And one analogy I recall her using, uh, discussing, discussing the power to build, for example, gene drives into mosquito populations was, was CRISPR, and how, uh, Dr. 31:04 Jennifer Doudna, who started CRISPR, really tried to very early on recognize the power that was there and, and tried to consider in her own lab and push the nascent CRISPR community to incorporate ethics from the top to make it a more transparent space for everyone. 31:23 And, and I imagine, and there have obviously been a few hiccups here and there, but that's probably a big part of the reason why CRISPR hasn't just been ripped loose everywhere so far. 31:32 But a-along the way, and even before that conversation we had, um, I recall, I mean, there are genetically modified mosquitoes have been released in, in Indonesia, uh, to try and combat dengue, and, and I know, uh, I believe recently Oxitec released a few hundred thousand, uh, engineered mosquitoes in the Florida Keys, uh, this year. 31:50 I, I, I saw one report, and again, please correct me if I'm wrong, that Aedes aegypti is only about four percent of the mosquito population in the Keys, but it was responsible for all of the mosquito-transmitted disease, which kinda tracks with what you were just saying about [chuckles] being a super predator. 32:06 But local folks were really against the release. 32:09 So i- you know, basically framing it as, you know, look, it's not super appealing to have a science experiment released in your backyard to see if it's gonna con- con-continue to kill you or not. 32:18 So I wonder if we can talk about ethics a-along this stuff. Uh, how much are ethics part of your lab's work? How much do you consider that when we talk about, you know, we-- "Look, this thing is happening. 32:30 We need new tools"? Yes. Those are great questions, and, and ethics is extremely important in, in the work that we do, and we think about it every single day. 32:39 Um, and I've, I've pre-- I've written, um, articles, you know, with social scientists and ethicists related to, uh, gene drives and genetic control of mosquitoes, um, i-in the past. 32:51 And so, uh, we think about it all the time. And, and, you know, just going back to your, uh, your point with the Florida Keys, um, uh, trial with the Oxitec mosquitoes, um, y-you're right. 33:03 There, there was a lot of resistance there, and, and people were, were afraid and, and they didn't wanna be guinea pigs, and, and they thought that, you know, "Why, why are they doing this in my backyard?" You know? 33:13 Um- Mm-hmm. And so there, there was that sentiment, but, but I think a lot of that stems from just, um, fear, um, of, of something go-going wrong. And- Mm-hmm. 33:23 And really that has to do with it being such a new technology, right? It's, it's- Sure. It is, it is relatively new. 33:30 Using, using genetically modified organisms to control populations is not something that, that is done regularly, right? And so there, there is gonna be that fear initially when you have a new technology. 33:43 But, you know, Oxitec has done its, its diligence and it-- and it's trialed this technology in many locations with, with great success. And, and, you know, in a lot of ways it's safer than what we're currently using. 33:56 Um, if you, if you go back and you just type in Zika and Florida on Google, you're gonna find- Mm. 34:01 You know, images of airplanes, like s-just spraying, uh, you know, neighborhoods, and you just, you just see the spray- Sure. Coming out of the back of the airplane, which is insecticides, right? 34:11 I mean, what is, what is the consequence of that, right? A hundred percent. And, and when you have a technology where you're, you're actually using the species to control itself, right? 34:22 I mean, it's, it's a really, it's a really nice technology because, you know, male mosquitoes know how to find females, right? 34:29 You just release them, they go out, they find them, they mate with them, and that will control the population. 34:33 And in a lot of ways, that's, that's far safer than what's currently being done, and I think it's just not well understood, and it-it's still a new... 34:41 considered a new tech-- a new approach in technology, and that people are just afraid of it in general. Sure. And I, and I think that context is essential, right? 34:49 Because it's not as if this is our first attempt at trying to stave off these infections and this, and this spread, and, and these disease vectors. 35:00 W-we have been trying, and again, these are intelligent species, uh, not to mention the viruses themselves. They're going to evolve and adapt like bacteria's been doing to all of our antibiotics. 35:12 You know, this isn't our first attempt, and wh-while of course we should be incredibly ethical and, and stop and, and ask, you know, how are we proceeding? Who are we affecting? Why are we doing this? 35:24 Uh, you know, are there any other options? Have we thought about the best way to test it and, and release it and promote it? 35:30 It's important to always put it up against what's already out there, and I mean, pesticides are, are a nightmare, right? 35:36 I mean, the, the number of flagrant existing issues, for example, we're losing bees, uh, everywhere. So I, I-- it's important, I feel like, to come back to first principles on these things, right? 35:51 Which is gene drives, uh, and, and technologies like this to, to, like you said, uh, the males are gonna go find the females. W- if we can do the work and they can control their own populations, great. 36:01 Um, pesticides have been a nightmare. They've helped in some ways, but obviously created a whole host of other issues all the way from, again, bees down to our soil doesn't really work as well anymore. 36:11 Like you said, images of planes dropping pesticides during, during Zika. Coming back to these fundamental building blocks, which is 36:18 th-these issues and these, uh, these animals have been there forever, but now one of the biggest issues is this overheating planet. 36:26 I-I'm curiousI- if you at all integrate that sort of multidisciplinary thinking into your work, which is, "Hey, guys, also we need to deal with climate change because California's getting way, way hotter, and it's becoming a breeding ground for this, [chuckles] for this thing I'm working on." 36:43 Uh, you know, it's not just heat death as an issue, it's not just, uh, crops, it's also becoming a much bigger disease factor for th- for this specific problem that has killed, like you said, [chuckles] more humans than anything else in history. 36:56 Do you guys think about climate change in your work at all? Uh, I'm curious. Yeah. Um, that's great. 37:02 Y- we do, we do think about climate change, but, but mostly in respect to how it's changing like vector, vector populations and, and, and sort of, you know, the, the movement of those species and, and, and along with that you get potentially more disease transmission. 37:17 I mean, we think about it in that respect, not, not so much of can we develop a technology in our lab that's gonna tackle climate change. We're not specifically working on that, on that chain... 37:26 on that, you know, you know, that goal to stop climate change, but we're working on sort of trying to develop tools that can, can combat sort of these, these, these problems that are gonna continue to become bigger problems as climate change, change continues. 37:41 So most of our focus right now is on, on mosquitoes and, and, and, you know, going back to your question about ethics and, and how we incorporate ethics into our work, you know, we've thought a lot about it, and really one of the big concerns right now with, with gene drive is that, you know, gene drive has the potential to sort of modify entire sp- entire species, right? 38:03 And- Mm-hmm. And, you know, the question is what is a, what is a modification that you're gonna, that you're gonna, that, that you're gonna use? 38:10 And so there's one, one use of gene drive is, is called population modification, where the goal is to spread a effector into a population that can provide a refractoriness to a pathogen. So for example- Mm-hmm... 38:25 malaria resistance, right? 38:27 So if you ha- have a gene that can prevent the mosquito from transmitting malaria, then the goal would be to, to spread that gene throughout the mosquito population, and then, you know, once it, once it reaches fixation, the mosquitoes will no longer be able to transmit malaria. 38:44 That- that's kind of- Mm-hmm... the goal of it, right? 38:46 But, you know, the problem is that, you know, you're, you know, with c- current gene drive designs, you know, we don't, we don't really understand enough about these effectors to, to sort of allow us to r- release mosquitoes that, that sort of encode these effectors into populations and allow them to spread everywhere, right? 39:07 Uncontrollably. Mm-hmm. Mm-hmm. We, we, we can't... 39:09 We, we wanna do it in a controlled way where we can sort of test these effectors and, and if they don't work or if something unintended happens, then we can remove that gene drive from the environment. 39:22 And so I think a lot of the ethics has to do with, okay, well, how can we, h- how can we release something that we, we can't control afterwards? And then who gives you permission? 39:33 Who, who, you know, who has a say in that, right? So if you release it- Mm-hmm... 39:36 in one location, and it can pretty much go everywhere, you know, is it okay for that, for, you know, just, just to get regulatory approval and, and public acceptance in, in just that one location, the initial release site, or do you need to get it everywhere, right? 39:51 And so these are just some of the ethical concerns that are kind of, um, on the table that people are actively discussing at the moment. 39:57 And so, you know, in our work, what we've been doing is actually sort of redesigning, um, genetic control systems to be, um, effective but controllable. 40:07 So we've, we've designed ways to use gene drives that allow only controlled spread in, in a, in a single population. Mm-hmm. 40:16 Um, and then we've also gone back and designed completely combinable genetic control systems that don't use gene drives that can also be used to eliminate populations of, of insects and animals. 40:28 So I think, you know, we, we definitely have listened and, and we've, uh, we agree that the concerns are valid and, and so maybe we're not ready to, to sort of, uh, unleash something we can't control- Sure... 40:42 at this, at this point in time, which is understandable. 40:44 And it doesn't mean that there are not other ways to design these systems to make them controllable to enable safe testing and also to, to potentially reduce disease transmission and save lives, and that's kinda what we're working on. 40:56 Sure, and it's not black and white, right? We can't just say, "Look, this thing is killing X number of people a day. Like, let's push this thing out." 41:02 Um, but at the same time, it is helpful to have that comparison, which is, you know, we have to take some shots at this because it is, it is, like you said, um, killed, killed [chuckles] billions of people throughout history and continues, uh, to do so. 41:15 I'm curious, what, what are some of the biggest, most, I guess, frequent obstacles that you and your lab run into in, in understanding these issues and developing these new mechanisms? Are they technical? 41:27 Are they ethical? Are they funding? Are they regulatory? I, I would say all of the above, [chuckles] you know? Um- [chuckles] Perfect. Yeah. I mean, y- you have to get funding to do the work- Sure... 41:37 which sometimes can be challenging. And, and then, you know, y- you wanna develop tools and systems that, that will be used, right? We don't wanna- Mm-hmm... 41:47 spend all of our time engineering something in the lab that's just gonna sit in our lab, you know? We wanna make sure- Sure... 41:53 that what we develop is what people need and want and, and what regulatories will allow us to use. 41:58 And so I think, you know, you have to kind of participate in all of these discussions in order to understand the complexities of, of, of what's happening in the world and what, what's really needed and, and wanted at this time, you know? 42:12 I think with mosquitoes, you know, I, I think with, with gene drive, for example, I, I don't think we're ready to, to release something that we can't control from what everything that I've participated in and, and, and heard from both regulator- regulators, ethicists, social scientists. 42:29 And, you know, if I didn't participate in those discussions-You know, I, I probably wouldn't realize that, right? And, and so 42:38 I think, you know, it, it's really important to, to, to be involved in all those discussions and, and to... And, and when you realize something is, is potentially not feasible, right? 42:49 Even though you can build something doesn't mean it's something we can ever use, right? Mm-hmm. 42:53 But when you realize that, I think it's important to go back to the drawing board a-and rethink, you know, h-how, how can we redesign this to, to, to fit the need, and I think that's, that's where we do a lot of our thinking in, in our group. 43:08 Well, I think that's pretty specific and obviously probably i-immensely more helpful than just, uh, crop dusting everything with, with pesticides, um, which a lot of drawbacks. 43:20 Doc, uh, so our goal is to provide, like I mentioned to you, these specific action steps our, our listeners can take to, to get involved for themselves, for the greater system, to support your mission with, as we say, sort of their, their voice and their, and their dollar. 43:34 And it, it can seem a little, I think, probably distant for folks, uh, to affect the implementation of, of mosquito gene drives around the world, right? 43:46 Unless they're already working on it or part of the regulatory system or policymaking and, and our audience has all of those, uh, folks in it for sure. 43:55 But at the same time, I, I imagine there are e-effective things that they can do. So, so let's try. Let's, let's start with their voice. 44:03 What are the sort of actionable but specific questions that, uh, the rest of us should be asking of our representatives? 44:09 Like, I know you mentioned, you know, the, the groups, and I apologize, I forget the, the nomenclature for the groups that, that will capture the mosquitoes locally and test them and, and things like that. 44:20 Wh-wh-where can people have an effect? Because obviously, mosquitoes biting you and making you sick is a pretty hyperlocal problem. Right. 44:26 You know, I, I think y- there's a, there's a lot of things that people can do, right, to sort of prevent themselves from, you know, being bitten by mosquitoes, for example. They could use repellents and things like that. 44:37 Um, and, you know, they can speak up too. I mean, they could... 44:40 You know, if, if they find that there's mosquitoes in their yard that, you know, were not a problem previously, they can call their, their local vector control program and, and, you know, there's one in almost every state. 44:53 Okay. And, and speak up and, and let them know, like, "Hey, look, we, we now have a mosquito problem that wasn't here prior, and we want, we want, we want solutions to this." Right? 45:03 And, you know, right now the, the best solutions are, are really, you know, mostly insecticide-based. 45:09 But hopefully, you know, in a matter of time, we will have more of these genetic control systems being trialed and, and potentially, you know, used in the environment. 45:19 And, and, and when that happens, I think we may, we may end up with more control o-of these mosquitoes. 45:25 But, but I think it's also important, you know, going back to the Oxitec example where, you know, people were very afraid of, of the technology and, and things like that. 45:35 I think it's also important for, for people to educate themselves on, on what, you know, what the problem is and how is it presently controlled and, and what are the risks, right? 45:44 And, and how have these, you know, how have these technologies been, been validated and, and used in the past. 45:51 And I think with the Oxitec example, you know, people may have, would have found that it's, it's a very safe technology. Honestly, it's, it's not something that is, um, predicted to cause any harms. 46:03 And, you know, it's been, it's been well, uh, vetted by the EPA. You know, they've, they've, they've done a lot of testing to, to determine whether there is any, um, adverse effects that could happen in the environment. 46:15 And, and they're, and they're continuing to do that, right? They're not just releasing it and, and hoping everything happens. 46:20 I mean, there, there are actually ongoing experiments that are being done that, that will validate whether it's being, um, you know, transmitted to other species and, and causing, um, effects in other species and things like that. 46:33 I mean, those, those are ongoing and, and you need to, you need that, you need to continue to do that while you perform the trial because, you know, you can't... 46:41 A lot of that information you can't get from a laboratory experiment. You have to do sort of a, a more area-wide experiment, which is what's happening here. 46:49 Is there a good, uh, source you can recommend, and, and if, if, if you need to do some thinking on it, we can just put it in the show notes, uh, that where people can educate themselves on, again, not ju- not just the specific experience in specific lo- uh, experiments in specific localities, but more how these things work to, to get a better understanding just in general, um, so that they are prepared when they're either advocating for them or finding out that it's happening locally. 47:16 Yeah. I mean, I think CDC, you know, has, has, um, information on their website for, you know, related to diseases. 47:23 And then, you know, um, in terms of specific genetic control systems, I think, you know, for the Oxitec example, they-- Oxitec has, has a website that's dedicated to, to that, that, that can be found online that, um, that will provide information about the trial and about the, about the, how the system works and, you know, uh, uh, you know, even their, their, um, approvals with the EPA and things like that can all be found there. 47:47 And I feel like it, it's, it's better for, for, for people to sort of, um, you know, educate themselves before they make a, make a decision on something, right? 47:57 They can't just, uh, automatically decide, "Okay, well, it's genetically engineered, I'm against it," right? 48:02 I think they need to go in and really, really think about it a little bit and compare to what's being, what's being used presently and, and make a decision after that, you know? 48:12 Um, but, but as, as we see more of these systems, you know, used in the environment, we, we generate more data on the safety, right? And so far they seem to be safer than anything that's, that's been used. 48:25 And so I, I think it's really important to get that message out. Absolutely. I think that makes sense. 48:30 And we'll, we'll find those, uh, those links and, uh, and we'll put them in the show notes for everybody so that they're accessible. Well, uh, do-Doc, I wanna thank you for all your time here today. 48:40 I don't wanna keep you. Obviously, you're working on some pretty important stuff out there. So we just have a last few questions we ask everybody if, if that's all right, uh, and then we'll get you out of here. Perfect. 48:50 Yeah. Sounds great. Awesome. 48:52 Doc, when was the first time in your life, uh, when you participated in something or realized you had the power of change or the power to do something meaningful, either, uh, alone or with a crowd or a partner, whatever it might be? 49:06 [laughs] Something meaningful. Um. Sure. Well, I- I'll just keep it, you know, mosquito-focused 'cause that's what this is, this is about. Sure. [chuckles] You know? 49:14 So I will say that, you know, while I was in college, I, I was getting a, um, a bachelor's, master's in biotechnology at the University of Nevada, Reno. 49:25 And, and that program required all the students to, to sort of work in labs. And I, I, I had the opportunity to work at, as a vector control intern at the Washoe County, uh, Vector Control District in, in Reno, Nevada. 49:39 Mm-hmm. And it, it was there where I, I sort of learned all about mosquitoes, right? I, I learned how to-- how they transmit pathogens. 49:47 I, I, I had my own sentinel chicken flocks where, you know, there was 10 flocks that were located all around town, and I would go collect blood from them every week and test them for transmitted pathogens like West Nile or St. 49:59 Louis encephalitis. Um, I had my own mosquito fish colony where I would go out and, and put mosquito fish in pe-- in ponds to- Mm-hmm... to sort of consume mosquito larvae. 50:10 And I also participated in, in helicopter aerial applications of insecticides. And I think- Hmm... I think it was my-- this experience, which I did for four summers, um, 50:20 really I, I learned comprehensively of how vector control is done. I did it firsthand. And, and how, in my opinion, how expensive and inefficient it is, right? Mm-hmm. 50:31 I mean, we, we were using the most advanced insecticides and, and, and hel-- literally helicopters to apply them, and am- mosquitoes would still, uh-- I would still find mosquitoes every week, right? 50:44 And, and so- Right... um, and that was in a, in a very developed area, you know, Reno, Nevada. 50:50 And so imagine how it looks in, in rural parts of Africa, for example, where you don't have that type of infrastructure or control. 50:59 And so, you know, that's where I realized, you know, that something, something, something better needs to be developed, right? Sure. 51:07 It, it wasn't just me reading a, [chuckles] like, you know, a textbook or, or anything like that. It was actually firsthand experience of applying insecticides and, and surveying mosquitoes and all that. 51:18 And, and I just... I, it, it was like in a, you know-- It hit me hard, like, "Okay, well, I need to go. I need to stay in school. I need to get a PhD. I need to develop something better." 51:30 And, and so after that program, the biotechnology program, I stayed on and got a PhD in cell and molecular biology, and I focused on insects. I wor- worked with flies, developmental biology of flies. 51:40 And then I, and then I went on to a postdoc at Caltech for six years and, and it was there where I really focused on genetic control systems. And I participated in seminars and, and, um, I learned from the best, right? 51:54 And, and, and that's where a lot of this-- these developments have, have sort of, um, you know-- That, that's where I've been inspired to, to sort of develop these, these, these different, um, genetic control systems. 52:07 That's awesome. 52:07 Well, uh, I mean, that's obviously a pretty, uh, crucial point in time for you, you know, watching it and taking part in something that, uh, is at that time the best we've got, but, you know, looking around and going, "This, this can't be it," you know. 52:21 "This can't be our, our best shot at taking care of these things." I always-- I f- I feel like we're gonna look back in, you know, a certain period of time, and we are already obviously do this. I mean, we look, 52:31 we look now, uh, you know, back prior to penicillin and, and, and, uh, you look at the difference between, uh, how casualties were treated in World War I versus World War II and, and, um, you know, obviously we still do it, but for a long time, the best answer was to just cut someone's leg off to stop infection, and that is thankfully not the case anymore. 52:51 Or, you know, now we're starting to ver- very, very slowly and, and strategically starting to move on from things like chemotherapy, which have been our best, uh, option in a lot of cases versus, uh, cancer, but can be just as brutal as the cancer itself. 53:07 And, and hopefully, you know, done ethically and strategically and, and considered well by folks like yourself, something like gene drives can be, um, far more useful and far less, uh-- have far less friendly fire, as they say, than something like incest- insecticides and, and pesticides, um, to try to, [sighs] 53:28 you know, control a, a very significant, uh, very wide-reaching problem. Yep. That's exactly, exactly right. Doc, who is someone in your life that has positively impacted your work in the past six months? 53:40 [laughs] The past six months have been, been challenging, to be honest with you. [laughs] Yeah. I'm, I'm sure. I've been, I've been on Zoom and, and isolated. I mean, uh, okay, so I, I would say, you know, 53:53 these last six months, I've-- I have been working remotely, um- Mm-hmm... exclusively. 54:00 And so all of, all of the work that, that, that, that has been done in my lab has been done by the people that I employ, which are the postdocs, the grad students, the students, you know, which have worked tremendously hard during such uncertain times. 54:16 And, and so, you know, I would say all of the impact of my work has been-- is, is handed off to them because they are the ones actually doing the work. I'm just sort of the, 54:27 uh, the director and, and sort of provide advice and, and, and thinking. So I would say the people that have impacted my work o- in the last six months are, are my direct, um, uh, the, the people that work in my lab. 54:41 That's awesome. 54:42 Well, uh, I, I can't imagineHow, uh, frustrating and difficult, uh, your work, [laughs] your work has been o-over the past year, so we're, we're thankful that you and, and all those folks in your lab have, have persevered certainly. 54:56 Um, quick pivot, Doc, what is your... Amid all this, what has your self-care been like? How have you taken care of yourself? 55:02 'Cause, you know, I've talked to any number of scientists over the past year and, um, it seems like finding that thing has been pretty essential to, to keeping your head on straight. Right. 55:12 I, I think i-initially, you know, it was, it was really hard, you know, like, having to leave the lab and, and not, not even have a lab for a period of time because everything got shut down. That was really challenging. 55:23 Um, and I think I just learned how to adapt, right? So initially- Mm-hmm... Zoom really sucked, right? I hated it. And I, um, you know, I still prefer in-person meetings, but I think over the last year, 55:36 over a year, year and a half almost, um, I've, I've gotten used to it. I've, I've learned how to, um, you know, use Zoom effectively and, and, and manage remotely, which, you know, I, I had never done prior. 55:50 And- Mm-hmm... and so, um, I, I can give you an example of, um, we have our, our weekly lab meeting and, you know, before it was in a conference room, you know, coffee, bagels, fruit, um, and it was enjoyable. 56:02 We'd go around table and, and, um, we would have ideas, and it was a, a lively discussion, right? And that switched to just a Zoom meeting, you know, and I've, uh, one of the ways I've sort of 56:14 d- dealt with it is I, every week I go to the beach. 56:17 So like I go down to La Jolla Shores, I put on my headphones, and I walk, I, I do my, um, Zoom meeting on my phone, and I just walk up and down the beach for two hours. 56:27 Um, and that helps me sort of, you know, um, uh, get my mind off, off what's going on and, and also to, to get some exercise so I'm not just sitting in my office all day at home. Sure. 56:38 Um, so I think those are some of the things I've done to, to, to sort of deal with it, but, um, I'm really looking forward to just, you know, getting back, getting back to normal at some point. 56:50 I think we all feel that way, Doc. Well, I'm glad you've, you've found ways to cope certainly. Um, last one. 56:56 What is a book you've read this year in all of that free time, uh, that has opened your mind to, uh, maybe a topic you hadn't considered, uh, or an angle you hadn't considered before, or it's actually changed your thinking in some way? 57:10 Yeah. Um, I, I've actually, I'd say over the last two months I've, I've read two books. One of them was The Code Breaker by Walter Isaacson, and the other was- Mm-hmm... is Editing Humanity by Kevin Davies. 57:21 And- Mm-hmm... I'm still, I'm only halfway through Editing Humanity. 57:24 Um, but, you know, The Code Breaker was a good one for me because, you know, we work with CRISPR and, and just hearing about all the heroes of CRISPR and, and sort of their, their story and how, how it progressed into, to what it is today was, was really inspiring. 57:39 And it, it actually has inspired us to sort of do a little bit of searching. 57:44 You know, we've, we've, we have some new projects in our lab where we're actually mining prokaryotic genomes for new types of, of, you know, bacterial, uh, uh, control systems that could be potentially manipulated for, for, for different purposes. 57:58 And so we've, we've actually, you know, through bioinformatics, we've identified a number of things that are really interesting, and I think it's taking us into different directions. 58:05 So I, I think that was all inspired from, from reading these books and, and it, it's just, um, yeah, that's, that's my answer. [laughs] That's pretty great. 58:16 Um, yeah, uh, Isaacson, boy, he, he did a great job with that one like he has in, in so many of the previous ones. Uh, it's pretty, pretty incredible, that story. Uh, listen, just wanna say thank you. 58:27 Uh, where, if anywhere, can our listeners follow you and your lab, uh, online or in the news? Yeah. Uh, I mean, uh, I have a Twitter account. You can find me on Twitter. Um, I'm also... I have a website at akbarilab.com. 58:42 Um, you can find me on there. There's, there's also a link on there for donating if anybody wants to donate to our, to our research. You can do it there. Oh, cool. 58:49 And, you know, we're, we're, we're regularly on the news. 58:52 You, you might find us on the news as well [laughs] and, um, yeah, I think those are the best places to reach me, and my email address is also located on our website, so you can- Cool... reach me directly if you want to. 59:03 Awesome. Um, well, listen, I can't thank you enough for your time today and, and all the work you're doing for a problem that, uh, is obviously gonna become much more prevalent, uh, in the US. 59:13 Um, hopefully, we can contain some of these larger outbreaks, but we're, we're trying to do a better job here of talking about things like adaptation when it comes to the climate crisis and such, and, um, uh, these are obviously all interdisciplinary or multidisciplinary, however you wanna phrase it, systemic issues. 59:31 Um, and mosquitoes have been around for a while, as are so many of the viruses they carry, but hopefully the work of folks like yourself can, uh, uh, can keep our, our hand out of the frying pan for, for a little while longer. 59:43 So thank you for all the thought you put into it and, and also obviously all the work you do under the microscope. Perfect. Um, yeah. Thank, thank you so much. 59:49 I really, I really enjoyed this, this interview and, um, looking forward to, to hearing it when it, when it, when it airs. Awesome. 59:57 [upbeat music] Thanks to our incredible guest today and thanks to all of you for tuning in. 1:00:03 We hope this episode has made your commute or awesome workout or dishwashing or fucking dog walking late at night that much more pleasant. 1:00:12 As a reminder, please subscribe to our free email newsletter at importantnotimportant.com. It is all the news most vital to our survival as a species. And you can follow us all over the internet. 1:00:23 You can find us on Twitter @importantnotimp. Just so weird. Also on Facebook and Instagram @importantnotimportant. Pinterest and Tumblr, the same thing. So check us out, follow us, share us, like us. You know the deal. 1:00:37 And please subscribe to our show wherever you listen to things like this. And if you're really fucking awesome, rate us on Apple Podcasts. Keep the lights on. Thanks. Please. 1:00:46 And you can find the show notes from today right in your little podcast player and at our website, importantnotimportant.com. 1:00:52 Thanks to the very awesome Tim Blaine for our jammin' music, to all of you for listening, and finally, most importantly, to our moms for making us. Have a great day. Thanks, guys. 1:01:04 [outtro music] [upbeat music] That's it for this week's conversation. 1:01:22 For more conversations, scroll back in the feed or visit podcast.importantnotimportant.com to search by name, topic, whatever. Thanks for sharing, thanks for leaving a review, and thanks for giving a shit. 1:01:44 [outtro music]